Diabetic kidney disease: Act now or pay later - World kidney day, 11 march 2010: We must act on diabetic kidney disease: Invited editorial

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 1, 2010, Pages 1-4

  Atkins, Robert C ^a   Zimmet, Paul ^b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HEALTH PROGRAM; HUMAN; KIDNEY DISEASE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

DIABETIC NEPHROPATHIES; HUMANS; SOCIETIES, MEDICAL; WORLD HEALTH;

EID: 77149159439     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00804.x     Document Type: Editorial

References (28)

1. International Diabetes Federation and International Society of Nephrology. Diabetes and Kidney Disease: Time to Act. Brussels : International Diabetes Federation and International Society of Nephrology, 2003.
2. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 414 : 782 787.
3. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 : 1414 1431.
4. Yoon K, Lee JH, Kim JW et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006 368 : 1681 1688.
5. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In : Gan D, ed. Diabetes Atlas, 3rd edn. Brussels : International Diabetes Federation, 2006 15 109.
6. Reutens AT, Prentice L, Atkins R. The epidemiology of diabetic kidney disease. In : Ekoé J et al., ed. The Epidemiology of Diabetes Mellitus, 2nd edn. Chichester : John Wiley & Sons, 2008 499 518.
7. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. International comparisons. 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007 239 254.
8. McDonald S, Excell L, Livingston B, eds. ANZDATA Registry Report 2008, Appendix II. Adelaide : Australia and New Zealand Dialysis and Transplant Registry, 2008 1 97.
9. Yamagata K, Iseki K, Nitta K et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol 2008 12 : 1 8.
10. Lysaght M. Maintenance dialysis population dynamics: current trends and long term implications. J Am Soc Nephrol 2002 13 : S37 40.
11. Adler A, Stevens RJ, Manley SE et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003 63 : 225 232.
12. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006 55 : 1832 1839.
13. Parving H, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006 69 : 2057 2063.
14. Ninomiya T, Perkovic V, de Galan BE et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009 20 : 1813 1821.
15. Dunstan D, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002 25 : 829 834.
16. White S, Polkinghorne KR, Cass A, Shaw J, Atkins RC, Chadban SJ. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008 188 : 204 208.
17. Whaley-Connell A, Sowers JR, McCullough PA et al. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009 53 (4 Suppl 4 S11 21.
18. Thomas M, Viberti G, Groop P. Screening for chronic kidney disease in patients with diabetes: are we missing the point? Nat Clin Pract Nephrol 2008 4 : 2 3.
19. Holman R, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 359 : 1577 1589.
20. Bilous R. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med 2008 25 (Suppl 2 25 9.
21. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008 358 : 580 591.
22. Patel A ADVANCE Collaborative Group, MacMahon S et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007 370 : 829 840.
23. ADVANCE Collaborative Group, Patel A, MacMahon S et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 358 : 2560 2572.
24. Zoungas S, de Galan BE, Ninomiya T et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care 2009 32 : 2068 2074.
25. Ruggenenti P, Fassi A, Ilieva AP et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004 351 : 1941 1951.
26. Parving H, Lehnert H, Brøchner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001 345 : 870 878. (Pubitemid 34940826)
27. Lewis E, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Eng J Med 2001 345 : 851 860.
28. Burney B, Kalaitzidis R, Bakris G. Novel therapies of diabetic nephropathy. Curr Opin Nephrol Hypertens 2009 18 : 107 111.